Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

New clinical study evaluating INKP-100 now in progress

Aug. 21, 1998

Selective beta3-adrenergic agents reported in development at Tokyo Tanabe

Aug. 19, 1998

Budesonide is superior to mesalamine in the treatment of Crohn's disease

Aug. 19, 1998

Results support development of beta-L-Fd4C as an expanded-spectrum anti-HBV drug

Aug. 18, 1998

FDA okays use of Engerix-B in patients with chronic HCV infection

Aug. 17, 1998

Results announced from primate studies of Nabi-Civacir

Aug. 17, 1998

New anti-H. pylori agents in development at Mitsubishi Chemical

Aug. 17, 1998

AU-006, a novel quinoline derivative with potent antiulcer activity

Aug. 14, 1998

Anti-H. pylori agents disclosed by Takeda

Aug. 12, 1998

Salofalk approved in Canada for the treatment of Crohn's disease

Aug. 12, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...